MARKET

MGTX

MGTX

Meiragtx Holdings Plc
NASDAQ
9.40
-0.55
-5.53%
After Hours: 9.40 0 0.00% 16:40 05/15 EDT
OPEN
9.88
PREV CLOSE
9.95
HIGH
9.94
LOW
9.36
VOLUME
768.59K
TURNOVER
--
52 WEEK HIGH
11.85
52 WEEK LOW
4.550
MARKET CAP
870.19M
P/E (TTM)
-6.6202
1D
5D
1M
3M
1Y
5Y
1D
MeiraGTx Holdings Is Maintained at Outperform by RBC Capital
Dow Jones · 23h ago
MeiraGTx Holdings Price Target Raised to $25.00/Share From $24.00 by RBC Capital
Dow Jones · 23h ago
RBC Capital Maintains Outperform on MeiraGTx Holdings, Raises Price Target to $25
Benzinga · 23h ago
Analysts Are Bullish on These Healthcare Stocks: Meiragtx Holdings (MGTX), CalciMedica (CALC)
TipRanks · 1d ago
MeiraGTx files Form 3 for Chief Development Officer Penny Renee Fleck
PUBT · 1d ago
Analysts Offer Insights on Healthcare Companies: Repligen (RGEN), Cardiff Oncology (CRDF) and Meiragtx Holdings (MGTX)
TipRanks · 1d ago
MeiraGTx grants CDO Penny Fleck 100,000 options, 100,000 RSUs as inducement award
PUBT · 1d ago
MEIRAGTX ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 1d ago
More
About MGTX
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company. It has a pipeline of late-stage clinical programs, including Parkinson’s disease, radiation-induced xerostomia and AIPL1-associated retinal dystrophy. It is focused on vivo delivery of vectorized biologic therapeutics addressing unmet needs in prevalent disorders, including severe forms of xerostomia, neurodegenerative diseases and ocular diseases, including inherited retinal diseases (IRDs), and large degenerative ocular diseases. The Company’s product pipeline includes Botaretigene Sparoparvovec for the treatment of X-linked Retinitis Pigmentosa; AAV-hAQP1 for the treatment of Radiation-Induced Grade 2/3 Xerostomia; AAV-hAQP1 for the treatment of Sjogren’s Syndrome; AAV-GAD for the treatment of Parkinson’s Disease; AAV-RPE65 for the treatment of RPE65-Associated Retinal Dystrophy; AAV-CNGB3 and AAV-CNGA3 for the treatment of Achromatopsia; AAV-AIPL1 for the treatment of LCA4, and others.

Webull offers MeiraGTx Holdings PLC stock information, including NASDAQ: MGTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MGTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MGTX stock methods without spending real money on the virtual paper trading platform.